Journal article
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
-
Kuhle J
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK/ Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.
-
Disanto G
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Dobson R
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Adiutori R
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Bianchi L
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Topping J
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Bestwick JP
Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and the London School for Medicine and Dentistry, UK.
-
Meier UC
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Marta M
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK.
-
Dalla Costa G
Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.
-
Runia T
Department of Neurology, Erasmus MC University Medical Center, The Netherlands.
-
Evdoshenko E
Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia.
-
Lazareva N
Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia.
-
Thouvenot E
Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France.
-
Iaffaldano P
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.
-
Direnzo V
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.
-
Khademi M
Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
-
Piehl F
Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
-
Comabella M
Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
-
Sombekke M
Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network.
-
Killestein J
Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network.
-
Hegen H
Department of Neurology, Innsbruck Medical University, Austria.
-
Rauch S
Department of Radiology, Innsbruck Medical University, Austria.
-
D'Alfonso S
Department of Health Sciences and IRCAD, Eastern Piedmont University, Italy.
-
Alvarez-Cermeño JC
Department of Neurology and Immunology, Hospital Ramón y Cajal, Spain.
-
Kleinová P
Department of Neurology, Charles University in Prague, Czech Republic.
-
Horáková D
Department of Neurology, Charles University in Prague, Czech Republic.
-
Roesler R
Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany.
-
Lauda F
Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany.
-
Llufriu S
Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain.
-
Avsar T
Dr Orhan Öcalgiray Molecular Biology-Biotechnology and Genetics Research Centre, Istanbul Technical University, Turkey.
-
Uygunoglu U
Department of Neurology, Istanbul University, Turkey.
-
Altintas A
Department of Neurology, Istanbul University, Turkey.
-
Saip S
Department of Neurology, Istanbul University, Turkey.
-
Menge T
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany.
-
Rajda C
Department of Neurology, University of Szeged, Hungary.
-
Bergamaschi R
C. Mondino National Neurological Institute, Italy.
-
Moll N
Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France.
-
Khalil M
Department of Neurology, Medical University of Graz, Austria.
-
Marignier R
Department of Neurology, Université de Lyon, Université Claude Bernard-Lyon 1, France.
-
Dujmovic I
Clinic of Neurology, Belgrade University School of Medicine, Serbia.
-
Larsson H
Unit of Functional Imaging, Glostrup Hospital, University of Copenhagen, Denmark.
-
Malmestrom C
Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden.
-
Scarpini E
Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico.
-
Fenoglio C
Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico.
-
Wergeland S
KG Jebsen Centre for MS-Research, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Norway.
-
Laroni A
Department of Neurology, University of Genoa, Italy.
-
Annibali V
Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy.
-
Romano S
Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy.
-
Martínez AD
Department of Neurology of Hospital Británico of Buenos Aires, Argentina.
-
Carra A
Department of Neurology of Hospital Británico of Buenos Aires, Argentina.
-
Salvetti M
Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy.
-
Uccelli A
Department of Neurology, University of Genoa, Italy.
-
Torkildsen Ø
KG Jebsen Centre for MS-Research, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Norway.
-
Myhr KM
Department of Neurology, University of Genoa, Italy.
-
Galimberti D
Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico.
-
Rejdak K
Department of Neurology, Medical University of Lublin, Poland.
-
Lycke J
Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden.
-
Frederiksen JL
Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark.
-
Drulovic J
Clinic of Neurology, Belgrade University School of Medicine, Serbia.
-
Confavreux C
Department of Neurology, Université de Lyon, Université Claude Bernard-Lyon 1, France.
-
Brassat D
Department of Neurology, University of Toulouse, France.
-
Enzinger C
Department of Neurology, Medical University of Graz, Austria.
-
Fuchs S
Department of Neurology, Medical University of Graz, Austria.
-
Bosca I
MS Unit, Neurology Department, La Fe University and Polytechnic Hospital, Instituto de investigación Sanitaria La Fe, Spain.
-
Pelletier J
Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France.
-
Picard C
Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France.
-
Colombo E
C. Mondino National Neurological Institute, Italy.
-
Franciotta D
C. Mondino National Neurological Institute, Italy.
-
Derfuss T
Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.
-
Lindberg R
Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.
-
Yaldizli Ö
Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.
-
Vécsei L
Department of Neurology, University of Szeged, Hungary.
-
Kieseier BC
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany.
-
Hartung HP
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany.
-
Villoslada P
Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain.
-
Siva A
Department of Neurology, Istanbul University, Turkey.
-
Saiz A
Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain.
-
Tumani H
Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany.
-
Havrdová E
Department of Neurology, Charles University in Prague, Czech Republic.
-
Villar LM
Department of Neurology and Immunology, Hospital Ramón y Cajal, Spain.
-
Leone M
MS Centre, SCDU Neurology, Head and Neck Department, AOU Maggiore della Carità, Italy.
-
Barizzone N
Department of Health Sciences and IRCAD, Eastern Piedmont University, Italy.
-
Deisenhammer F
Department of Neurology, Innsbruck Medical University, Austria.
-
Teunissen C
Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network.
-
Montalban X
Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
-
Tintoré M
Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
-
Olsson T
Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
-
Trojano M
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.
-
Lehmann S
Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France.
-
Castelnovo G
Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France.
-
Lapin S
Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia.
-
Hintzen R
Department of Neurology, Erasmus MC University Medical Center, The Netherlands.
-
Kappos L
Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland.
-
Furlan R
Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.
-
Martinelli V
Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.
-
Comi G
Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy.
-
Ramagopalan SV
Department of Physiology, Anatomy and Genetics and Medical Research Council Functional Genomics Unit, University of Oxford, UK.
-
Giovannoni G
Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK g.giovannoni@qmul.ac.uk.
Show more…
Published in:
- Multiple sclerosis (Houndmills, Basingstoke, England). - 2015
English
BACKGROUND AND OBJECTIVE
We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort.
METHODS
Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS.
RESULTS
At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres.
CONCLUSIONS
We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/109822
Statistics
Document views: 5
File downloads: